A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response - sprookjes - yvandenbroek - TriplyDB

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

http://www.wikidata.org/entity/Q33857617

about

PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha Endoplasmic reticulum stress-activated C/EBP homologous protein enhances nuclear factor-kappaB signals via repression of peroxisome proliferator-activated receptor gamma Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity Blasts from the past Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands Receptor Ck-dependent signaling regulates hTERT gene transcription.PPARγ and the Innate Immune System Mediate the Resolution of Inflammation NLRP6 in infection and inflammation Intestinal Antigen-Presenting Cells: Key Regulators of Immune Homeostasis and Inflammation Nutritional protective mechanisms against gut inflammation Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.Pioglitazone, a specific PPAR-gamma ligand, inhibits aspirin-induced gastric mucosal injury in rats Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells The peroxisome: still a mysterious organelle Inflammatory bowel disease Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ Roles of PPARγ/NF-κB signaling pathway in the pathogenesis of intrahepatic cholestasis of pregnancy.Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis.Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma.Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis.Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.PPARγ agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages.The importance of the retinoid X receptor alpha in modulating inflammatory signaling in acute murine colitis.Minireview: Challenges and opportunities in development of PPAR agonists Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data.Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice.Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.Effects of rosiglitazone on inflammation in Otsuka long-evans Tokushima Fatty rats.Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice The PXR is a drug target for chronic inflammatory liver disease.Gastrointestinal Cytoprotection by PPARγ Ligands.Peroxisome proliferator activated receptor-γ and traumatic brain injury.

P2860

Q23911525-22061D1D-F4F2-4942-8DEF-9D5F6FE19471 Q23914416-3ED11204-0D06-4472-9A88-B3341153DF38 Q24299225-16B82107-EE48-47D3-85A2-D11AB87EBC25 Q24322799-6D40E6C5-D36D-4242-856D-112DE2D7558D Q24563415-D54AE2A8-F102-4E74-99EA-EF50420681D7 Q24793384-789133F5-6F16-4E38-8FB5-4BCEABC0C09C Q24796541-AA7E4D12-2F9F-4FED-A350-CCF0B419A02B Q24810709-3AD2CF3F-3ADB-4FD3-B916-5F0B537250DA Q25255748-205C866E-653D-4AE5-9070-7029E001BCFF Q26771755-373215A5-ADCA-44AD-9466-1AABD39F880D Q26830237-D738A548-C2C8-46E6-83F0-307198804E44 Q26862770-2A515F89-4283-42EB-9835-8953AED000C2 Q27028202-24B0BC37-FCFB-4CE3-A58F-93304F119924 Q27687166-07101EFD-3E1A-4313-8889-47580C07F14B Q28184352-4D6CCE61-52EB-4633-B82B-151DAE8596C1 Q28564168-DCD42A37-20C5-4C7A-8AD9-1C3DBF70885C Q28570331-5B1694F2-A426-4601-9143-BE7D3DA6D308 Q28741411-A239A0D9-8856-444B-992C-848003777375 Q28754736-79B551C7-17EA-4B7E-BC54-F4E7DEE628D7 Q29615500-0B66D922-213C-4CFE-8DBF-3ECD7ADF6A77 Q30440147-32A184AF-52E9-4600-9EC0-74B5086E1DE6 Q30538765-212F7BC6-38ED-4FFB-98B5-E7CE4C7CE1E5 Q31149202-903914ED-773A-4120-868E-80244D27F38A Q33180568-0664C0D7-9321-484E-BC2C-60DE84375816 Q33196298-18AC6784-442E-4AE4-9D7F-E802D7578796 Q33231851-64608CDA-2185-4AD6-82CC-0405BE0A0326 Q33493427-9660CB0C-0548-4DEF-873B-7B3984C8EA90 Q33556872-A5519B30-84ED-4903-8E3C-42EAB8121A53 Q33565057-2F6C6548-F3AF-4281-9D3D-72F1A1824530 Q33631921-FB4D0215-EE79-4972-8D5E-F5E03DF31904 Q33644063-B000290A-DF99-4F7A-A19C-D30D634B0698 Q33644094-F3A5C045-95E5-497B-AEB1-69A4AB45B3FB Q33694542-595BE4B3-BE03-472B-ADDC-80F8ABFAA973 Q33712428-580C357C-81C1-4081-ADBB-77A7D8A3371D Q33964333-1FB5C5E6-E4EA-41E9-B995-59915A57ACE2 Q33969599-5EE67F92-E3AE-45B0-8735-76540D54DA67 Q34032853-365BCE16-305F-4600-A34A-E15DE7161918 Q34118368-41CDEF3B-E1DE-4FB5-A116-82FBAEAADB2C Q34159427-4C987A4C-7D55-4D88-9B9D-DD2DB3749686 Q34271250-46EE4F26-28B7-499F-A59E-5FC8E44ABBF3

P2860

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

http://www.wikidata.org/entity/Q33857617

description

1999 nî lūn-bûn

@nan

1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

A novel therapy for colitis ut ...... ithelial inflammatory response

@ast

A novel therapy for colitis ut ...... ithelial inflammatory response

@en

type

label

A novel therapy for colitis ut ...... ithelial inflammatory response

@ast

A novel therapy for colitis ut ...... ithelial inflammatory response

@en

prefLabel

A novel therapy for colitis ut ...... ithelial inflammatory response

@ast

A novel therapy for colitis ut ...... ithelial inflammatory response

@en

P1433

Q33857617-E97BF87D-3ECF-4219-B232-822FDE1A3E49

P1476

Q33857617-8C8D0172-76AE-44FD-A00E-27D4E54AEA58

P2093

Q33857617-29F85253-A4EA-4C0E-B8C6-79591CB29B62

Q33857617-3335339A-42B0-459F-AA39-A2A135A07E86

Q33857617-43A05A39-E215-49A7-86E9-7ABAA41F3687

Q33857617-4E60E374-5E25-4A5B-A9B1-A313E329F868

Q33857617-64E7D8C9-EADD-4A6D-A98A-99E2BBF35C62

Q33857617-A4744DEA-6D70-4294-931E-8DFABF3ABDC8

Q33857617-C47C626B-97D9-4BFD-9F79-6B3ED21D8B1F

Q33857617-C8068921-55DD-4E7D-AACD-2403984E406F

Q33857617-DE84C9FC-4C9D-4BD5-A52A-62ED704A62B9

Q33857617-F33CAD9A-3A95-4160-85AD-7301BA3ED4BE

P2860

Q33857617-006B2749-3CE0-4D14-B426-6BF2BDBBC644

Q33857617-087529AC-7BA0-4170-9BE0-821AA66F84E8

Q33857617-0DE9CE11-7EA5-45EE-B19A-BD1F8EC23642

Q33857617-16B5B3B6-B065-4DF3-AD3F-7A29DA6F3785

Q33857617-1F24389C-F1AF-4194-B175-BAB0A80F2F01

Q33857617-234D74AC-BC37-435D-A765-6EE48F9879A6

Q33857617-351CADB5-05B9-431A-830F-01F4B5279449

Q33857617-4102A672-4B61-4C8F-A9F9-90B2BB5F93AD

Q33857617-423F9734-52CD-4811-9080-DC69EFF55B7E

Q33857617-489F87B4-52BE-4E62-97FB-71324FC55491

P304

Q33857617-843A36B9-F641-4F68-89F3-E252C86F08CF

P31

Q33857617-AED076CF-5920-44D7-88CF-1CAC35D1A4A6

P356

Q33857617-4AA52D4B-0AC4-46E7-BAE8-783690C0B00A

P407

Q33857617-C31B9EE2-72E3-4966-B6DC-C019218CABA1

P433

Q33857617-18E24EEF-9CC0-47FB-AD98-421F028CEA35

P478

Q33857617-9DDC0C90-E870-47D5-AE91-21AAD2C68276

P577

Q33857617-367ADBA1-8283-4581-BB43-EE948B1E45B9

P698

Q33857617-64DCAFE6-E883-423D-A717-73B95CBC2E68

P921

Q33857617-07DB1F3D-7A03-4E15-89C0-7CDF1FF4854A

P932

Q33857617-ED1A39E3-DDEB-4B6C-946C-7069843A42AC

P356

P1433

Journal of Clinical Investigation

P1476

A novel therapy for colitis ut ...... ithelial inflammatory response

@en

P2093

A Flanigan

http://www.w3.org/2001/XMLSchema#string

C G Su

http://www.w3.org/2001/XMLSchema#string

G D Wu

http://www.w3.org/2001/XMLSchema#string

M A Lazar

http://www.w3.org/2001/XMLSchema#string

S A Keilbaugh

http://www.w3.org/2001/XMLSchema#string

S M Rangwala

http://www.w3.org/2001/XMLSchema#string

S Murthy

http://www.w3.org/2001/XMLSchema#string

S T Bailey

http://www.w3.org/2001/XMLSchema#string

W Jiang

http://www.w3.org/2001/XMLSchema#string

X Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

High-efficiency transformation of mammalian cells by plasmid DNA

The organization, promoter analysis, and expression of the human PPARgamma gene

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

P304

383-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI7145

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10449430

http://www.w3.org/2001/XMLSchema#string

P921

P932

408529

http://www.w3.org/2001/XMLSchema#string